Vira Shield 6+VL5 HB [250ml] (50 Dose)

Vira Shield 6 + VL5 HB - 50 Dose is for use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Types 1 & 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. Vira Shield 6 VL5 HB cattle vaccine from Novartis is a killed virus and bacterin for use in healthy breeding cattle as an aid in the prevention of diseases caused by IBR, PI3, BRSV, cytopathic and noncytopathic BVD Type 1, noncytopathic BVD Type 2, Vibrio and the 5 most common strains of Lepto.

For use in calves vaccinated at four weeks of age, or older, as an aid in the prevention of hardjo-bovis kidney colonization, and as an aid in preventing urinary shedding and reproductive tract infection for 12 months. Produced from non-cytopathic (BVD Types 1 & 2) and cytopathic (BVD Type 1) isolates. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (Type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.

Vira Shield 6+VL5 HB [250ml] (50 Dose) Highlights:

• SKU: 12346
• Manufacturer: Elanco
• Transient swelling may occur at the site of injection.
• Bovine Rhinotracheitis (IBR) fetal protection eight months post vaccination.
• Produced from non-cytopathic (BVD Types 1 & 2) and cytopathic (BVD Type 1) isolates.
• Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter.
• Vira Shield 6 offers broad spectrum protection as it is the first vaccine to contain three BVD antigens.
• Consistently produces higher litters due to state-of-the-art adjuvant (Xtend SP), prolonging stimulation of the immune system.